Page last updated: 2024-10-24

positive regulation of transdifferentiation

Definition

Target type: biologicalprocess

Any process that activates or increases the frequency, rate or extent of transdifferentiation. [GO_REF:0000058, GOC:TermGenie, PMID:22118091]

Positive regulation of transdifferentiation is a complex biological process that involves a cascade of molecular events leading to the conversion of one cell type into another. This process is tightly regulated and involves a coordinated interplay of signaling pathways, transcription factors, and epigenetic modifications.

**Key steps involved in positive regulation of transdifferentiation:**

1. **Signal Induction:** Transdifferentiation is often initiated by external signals, such as growth factors, cytokines, or environmental cues. These signals activate specific signaling pathways, which in turn modulate the expression of key transcription factors.
2. **Transcription Factor Activation:** Transcription factors play a crucial role in regulating gene expression and directing the transition from one cell fate to another. Specific transcription factors are activated or repressed in response to the inducing signals, leading to the expression of genes associated with the target cell type.
3. **Epigenetic Modifications:** Epigenetic modifications, such as DNA methylation and histone acetylation, can play a significant role in regulating gene expression during transdifferentiation. These modifications can alter chromatin accessibility and influence the binding of transcription factors to target genes.
4. **Cellular Reprogramming:** As the expression of specific genes is altered, the cell undergoes a process of reprogramming, leading to changes in its morphology, function, and identity. This involves the downregulation of genes associated with the original cell type and the upregulation of genes associated with the target cell type.
5. **Cell Fate Commitment:** Over time, the transdifferentiating cell commits to its new identity, becoming a functional cell of the target cell type. This process is often accompanied by the formation of new cellular structures and the acquisition of specialized functions.

**Examples of transdifferentiation:**

- **Fibroblast to myoblast transdifferentiation:** Fibroblasts, connective tissue cells, can be induced to transdifferentiate into myoblasts, muscle precursor cells, by treatment with growth factors such as fibroblast growth factor (FGF).
- **Pancreatic beta cell transdifferentiation:** Pancreatic alpha cells, which produce glucagon, can be induced to transdifferentiate into beta cells, which produce insulin, by manipulating the expression of key transcription factors.

**Factors influencing positive regulation of transdifferentiation:**

- **Cell type:** The efficiency and outcome of transdifferentiation can vary depending on the cell type being reprogrammed.
- **Inducing signals:** The specific signals used to induce transdifferentiation can influence the target cell type and the overall efficiency of the process.
- **Epigenetic modifications:** The epigenetic landscape of the cell can significantly affect the outcome of transdifferentiation.
- **Cellular context:** The cellular environment and the presence of neighboring cells can also influence transdifferentiation.

**Applications of transdifferentiation:**

Transdifferentiation holds great promise for regenerative medicine and disease modeling. For example, it may be possible to generate functional cells for transplantation from readily available sources, such as fibroblasts or skin cells. Transdifferentiation may also provide valuable insights into the mechanisms of cell fate determination and the development of diseases.
'"

Proteins (1)

ProteinDefinitionTaxonomy
Telomerase reverse transcriptaseA telomerase reverse transcriptase that is encoded in the genome of human. [PRO:DNx, UniProtKB:O14746]Homo sapiens (human)

Compounds (28)

CompoundDefinitionClassesRoles
7,8-dihydroxyflavone7,8-dihydroxyflavone : A dihydroxyflavone that is flavone substituted by hydroxy groups at positions 7 and 8. A dihydroxyflavone that is flavone substituted by hydroxy groups at positions 7 and 8. A naturally occurring flavonoid produced by several plants, including the weed Tridax procumbens (coalbuttons or tridax daisy) and the tree Godmania aesculifolia, In animal models, it has shown efficacy against several diseases of the nervous system, including Alzheimer's, Parkinson's, and Huntington's.dihydroxyflavoneantidepressant;
antineoplastic agent;
antioxidant;
plant metabolite;
tropomyosin-related kinase B receptor agonist
ethacridineEthacridine: A topically applied anti-infective agent.acridines
berberinealkaloid antibiotic;
berberine alkaloid;
botanical anti-fungal agent;
organic heteropentacyclic compound
antilipemic drug;
antineoplastic agent;
antioxidant;
EC 1.1.1.141 [15-hydroxyprostaglandin dehydrogenase (NAD(+))] inhibitor;
EC 1.1.1.21 (aldehyde reductase) inhibitor;
EC 1.13.11.52 (indoleamine 2,3-dioxygenase) inhibitor;
EC 1.21.3.3 (reticuline oxidase) inhibitor;
EC 2.1.1.116 [3'-hydroxy-N-methyl-(S)-coclaurine 4'-O-methyltransferase] inhibitor;
EC 2.1.1.122 [(S)-tetrahydroprotoberberine N-methyltransferase] inhibitor;
EC 2.7.11.10 (IkappaB kinase) inhibitor;
EC 3.1.1.4 (phospholipase A2) inhibitor;
EC 3.1.1.7 (acetylcholinesterase) inhibitor;
EC 3.1.1.8 (cholinesterase) inhibitor;
EC 3.1.3.48 (protein-tyrosine-phosphatase) inhibitor;
EC 3.4.14.5 (dipeptidyl-peptidase IV) inhibitor;
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor;
geroprotector;
hypoglycemic agent;
metabolite;
potassium channel blocker
9,10-phenanthrenequinone9,10-phenanthrenequinone: structurephenanthrenes
ethidium bromideorganic bromide saltgeroprotector;
intercalator;
trypanocidal drug
camptothecinNSC 100880: carboxylate (opened lactone) form of camptothecin; RN refers to (S)-isomer; structure given in first sourcedelta-lactone;
pyranoindolizinoquinoline;
quinoline alkaloid;
tertiary alcohol
antineoplastic agent;
EC 5.99.1.2 (DNA topoisomerase) inhibitor;
genotoxin;
plant metabolite
staurosporineindolocarbazole alkaloid;
organic heterooctacyclic compound
apoptosis inducer;
bacterial metabolite;
EC 2.7.11.13 (protein kinase C) inhibitor;
geroprotector
acridine orangeacridine orange : Fluorescent dye useful for cell cycle determination. It is cell-permeable, and interacts with DNA and RNA by intercalation or electrostatic attractions respectively.

acridine orange free base : A member of the class of aminoacridines that is acridine carrying two dimethylamino substituents at positions 3 and 6. The hydrochloride salt is the fluorescent dye 'acridine orange', used for cell cycle determination.

Acridine Orange: A cationic cytochemical stain specific for cell nuclei, especially DNA. It is used as a supravital stain and in fluorescence cytochemistry. It may cause mutations in microorganisms.
aminoacridines;
aromatic amine;
tertiary amino compound
fluorochrome;
histological dye
epigallocatechin gallate(-)-epigallocatechin 3-gallate : A gallate ester obtained by the formal condensation of gallic acid with the (3R)-hydroxy group of (-)-epigallocatechin.

epigallocatechin gallate: a steroid 5alpha-reductase inhibitor and antimutagen in green tea (Camellia sinensis)
flavans;
gallate ester;
polyphenol
antineoplastic agent;
antioxidant;
apoptosis inducer;
geroprotector;
Hsp90 inhibitor;
neuroprotective agent;
plant metabolite
meridinemeridine: polycyclic alkaloid derived from the marine sponge Corticium sp; structure given in first source
cryptolepinecryptolepine : An organic heterotetracyclic compound that is 5H-indolo[3,2-b]quinoline in which the hydrogen at position N-5 is replaced by a methyl group.

cryptolepine: fused indole-quinoline; structure in first source; from CRYPTOLEPIS sanguinolenta
indole alkaloid;
organic heterotetracyclic compound;
organonitrogen heterocyclic compound
anti-inflammatory agent;
antimalarial;
antineoplastic agent;
cysteine protease inhibitor;
plant metabolite
quindolinequindoline: a fused indole-quinoline alkaloid from CRYPTOLEPIS sanguinolenta; structure
u 731221-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione: structure given in first source

U-73122 : An aza-steroid that is 3-O-methyl-17beta-estradiol in which the 17beta-hydroxy group is replaced by a 6-(maleimid-1-yl)hexylamino group. An inibitor of phospholipase C.
aromatic ether;
aza-steroid;
maleimides
EC 3.1.4.11 (phosphoinositide phospholipase C) inhibitor
celastrolmonocarboxylic acid;
pentacyclic triterpenoid
anti-inflammatory drug;
antineoplastic agent;
antioxidant;
EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor;
Hsp90 inhibitor;
metabolite
alteichinalteichin: unusual phytotoxin from Alternaria eichorniae, fungal pathogen of water hyacinth; doubly hydrated form of 4,9-dihydroxyperylene-3,10-quinonepolyphenol
3',4'-dihydroxyflavone3',4'-dihydroxyflavone: inhibitors of arachidonic acid peroxidation
tanshinone ii atashinone IIA: a cardiovascular agent with antineoplastic activity; isolated from Salvia miltiorrhiza; structure in first sourceabietane diterpenoid
Telomestatin1,3-oxazoles
7,8,3'-trihydroxyflavone7,8,3'-trihydroxyflavone: a potent small molecule TrkB receptor agonist that protects spiral ganglion neurons from degeneration both in vitro and in vivo
2-(3,4-dihydroxyphenyl)-7,8-dihydroxy-1-benzopyran-4-oneflavones
7,8,4'-trihydroxyflavone
okaninokanin : A member of the class of chalcones that is trans-chalcone substituted by hydroxy groups at positions 3, 4, 2', 3', and 4' respectively.

okanin: hypoglycemic from Coreopsis tinctoria; structure in first source
benzenetriol;
chalcones
plant metabolite
3',4',7-trihydroxyflavone3',4',7-trihydroxyflavone: from the Sudanese medicinal plant Albizia zygia; structure in first sourceflavones
beta-rubromycinbeta-rubromycin: structure given in first source
mkt 077MKT 077: structure given in first source
braco-19BRACO-19: structure in first sourceacridines;
N-alkylpyrrolidine
bibr 1532
n'-(10h-indolo(3,2-b)quinolin-11-yl)-n,n-dimethylpropane-1,3-diamine